Literature DB >> 17039164

Acute motor-sensory axonal neuropathy associated with active systemic lupus erythematosus and anticardiolipin antibodies.

E E Ubogu1, O O Zaidat, J I Suarez.   

Abstract

Acute motor-sensory axonal neuropathy (AMSAN) is an axonal variant of Guillian-Barré syndrome (GBS) that presents with acute ascending quadriparesis. This has generally been described in association with Campylobacter jejuni infections or with anti-ganglioside antibodies. Known cases have shown a slow recovery and a poor prognosis. We report a case with clinical and electrophysiological evidence of AMSAN in association with active systemic lupus erythematosus (SLE) and anticardiolipin antibodies but not the other associations, with a rapid response to combination immunosuppressant and intravenous immunoglobulin (IVIg) therapy. The association between AMSAN and SLE has not been previously described. This case illustrates that early recognition and the utilization of electrophysiologic techniques may be beneficial in the diagnosis and management of GBS associated with SLE. Fulminant or rapidly progressive cases should be managed in specialized intensive care units. Combination therapy of immunosuppressants and IVIg may be beneficial in non-vasculitic axonal radiculo-neuropathies associated with SLE, resulting in good outcomes.

Entities:  

Year:  2001        PMID: 17039164     DOI: 10.1097/00124743-200110000-00014

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  7 in total

1.  Therapeutic Plasma Exchange in Neurologic Diseases: An Experience with 91 Patients in Seven Years.

Authors:  Sibel Karaca; İlknur Kozanoğlu; Başak Karakurum Göksel; Mehmet Karataş; Meliha Tan; V Deniz Yerdelen; Semih Giray; Zülfikar Arlier
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

2.  Acute motor-sensory axonal neuropathy associated with systemic lupus erythematosus.

Authors:  Smathorn Thakolwiboon; Amputch Karukote; Gyeongmo Sohn
Journal:  Proc (Bayl Univ Med Cent)       Date:  2019-08-20

3.  Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.

Authors:  John G Hanly; Qiuju Li; Li Su; Murray B Urowitz; Caroline Gordon; Sang-Cheol Bae; Juanita Romero-Diaz; Jorge Sanchez-Guerrero; Sasha Bernatsky; Ann E Clarke; Daniel J Wallace; David A Isenberg; Anisur Rahman; Joan T Merrill; Paul R Fortin; Dafna D Gladman; Ian N Bruce; Michelle Petri; Ellen M Ginzler; M A Dooley; Kristjan Steinsson; Rosalind Ramsey-Goldman; Asad A Zoma; Susan Manzi; Ola Nived; Andreas Jonsen; Munther A Khamashta; Graciela S Alarcón; Elisabet Svenungsson; Ronald F van Vollenhoven; Cynthia Aranow; Meggan Mackay; Guillermo Ruiz-Irastorza; Manuel Ramos-Casals; S Sam Lim; Murat Inanc; Kenneth C Kalunian; Soren Jacobsen; Christine A Peschken; Diane L Kamen; Anca Askanase; Chris Theriault; Vernon Farewell
Journal:  Arthritis Rheumatol       Date:  2019-11-28       Impact factor: 10.995

Review 4.  Indications for IVIG in rheumatic diseases.

Authors:  Ben Mulhearn; Ian N Bruce
Journal:  Rheumatology (Oxford)       Date:  2014-11-17       Impact factor: 7.580

5.  Weakness and the inability to ambulate in a 14-month-old female: a case report and concise review of guillain-barre syndrome.

Authors:  Scott A Bloch; Mahsa Akhavan; Jahn Avarello
Journal:  Case Rep Emerg Med       Date:  2013-01-30

Review 6.  Management of rheumatoid arthritis: the 2012 perspective.

Authors:  Hisashi Yamanaka; Yohei Seto; Eiichi Tanaka; Takefumi Furuya; Ayako Nakajima; Katsunori Ikari; Atsuo Taniguchi; Shigeki Momohara
Journal:  Mod Rheumatol       Date:  2012-07-07       Impact factor: 3.023

Review 7.  Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases.

Authors:  Delia Tulbă; Bogdan Ovidiu Popescu; Emilia Manole; Cristian Băicuș
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.